Clinical Trials Directory

Trials / Completed

CompletedNCT04780386

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2

A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
58 (actual)
Sponsor
NVP Healthcare · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2.

Detailed description

pharmacokinetics and safety of NVP-1805 compared to coadministration of NVP-1805-R1 with NVP-1805-R2

Conditions

Interventions

TypeNameDescription
DRUGNVP-1805orally, once daily on Period 1 and Period 3 (or Period 2 and Period 4)
DRUGNVP-1805-R1and NVP-1805-R2orally, once daily on Period 1 or Period 3 (or Period 2 and Period 4)

Timeline

Start date
2020-08-29
Primary completion
2020-11-02
Completion
2021-02-16
First posted
2021-03-03
Last updated
2021-03-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04780386. Inclusion in this directory is not an endorsement.

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 (NCT04780386) · Clinical Trials Directory